SKILLMAN, N.J., Sept. 3 /PRNewswire/ -- ConvaTec, a world leader in the development and marketing of innovative wound therapeutics and ostomy care products, today announced it has completed the acquisition of Unomedical. Unomedical is a Copenhagen-based manufacturer of single-use medical devices. The combination will create a company with $1.6 billion in annual sales with a significantly expanded global footprint.
The combined company will be known as ConvaTec and will be led by current ConvaTec CEO, David Johnson. ConvaTec will have four business divisions: Ostomy Care, Wound Therapeutics, Continence & Critical Care, and Infusion Devices. Infusion Devices will continue to operate separately. As required by the European Competition Commission, the integration will not include the Unomedical Wound Care division, which will be divested within the next several months.
"This is a tremendous day for our customers, our employees and our business," said David Johnson, CEO, ConvaTec. "As two global healthcare leaders, we are uniquely positioned to build on each other's strengths. By joining forces, our combined company will be able to offer our customers around the world an unprecedented portfolio of comprehensive best-in-class solutions."
With complementary portfolios in acute care and home healthcare, the combined company will be a much larger driving force in the industry, with an expanded offering of products and product-related services for customers around the world. Unomedical's strong presence in hospitals and intensive care, especially deep throughout Europe, will complement ConvaTec's existing strengths in community and home-based care.
Johnson continued, "Together, we are poised for accelerated growth and innovation. Most importantly, we share the same goal -- to improve the lives of patients and to support healthcare professionals globally."
For over 30 years, ConvaTec has been a pioneer in developing and marketing innovative wound therapeutics and ostomy care products that have helped improve the lives of millions of people worldwide. Today, ConvaTec continues to be at the forefront of the movement to change the way healthcare professionals are managing chronic and acute wounds, emphasizing the principles of advanced wound care management and evidence-based medicine. From its headquarters in Skillman, New Jersey, the company oversees more than 3,500 employees in 91 countries serving patients and their healthcare professionals on six continents. ConvaTec is owned by Nordic Capital and Avista Capital Partners. For more information, please visit www.convatec.com.
Unomedical is a leading provider of single-use medical devices with global operations. Within Hospital Care, Unomedical is one of Europe's leading companies and it has strong niche positions overseas. Within Infusion Devices, Unomedical is a global market leader within infusion sets used by diabetics on pump therapy. Based in Birkerod, Denmark, Unomedical has product development, manufacturing and sales offices worldwide and employs some 4,500 employees in 14 countries. For more information, please visit www.unomedical.com.
CONTACT: Nimisha Savani of ConvaTec, +1-908-904-2522,
Nimisha.Savani@convatec.com; or Punnie Donohue of Weber Shandwick,
+1-212-445-8163, PDonohue@webershandwick.com, or Harry Levin of OutCom,
+45-33-12-19-00, Levin@outcom.dk, both for ConvaTec
Web site: http://www.convatec.com/